EII:FRA
Eisai Co Ltd
ā¬26.71
arrow_downward
-0.45%(-0.12) 1D
Okt 1, 8:30:03āÆPM GMT+2 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa EII...
Buksan
ā¬26.75
Mataas
ā¬26.75
Mababa
ā¬26.71
Mkt. cap
9.25B
Avg. na dami
38.00
Dami
50.00
Mataas nang 52-wk
ā¬29.01
Mababa nang 52-wk
ā¬19.70
Bilang ng mga empleyado
11K
Buksan
ā¬26.75
Mataas
ā¬26.75
Mababa
ā¬26.71
Mkt. cap
9.25B
Avg. na dami
38.00
Dami
50.00
Mataas nang 52-wk
ā¬29.01
Mababa nang 52-wk
ā¬19.70
Bilang ng mga empleyado
11K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Simply Wall Street
·
4 oras ang nakalipas
Did Kidney Cancer Approval Just Shift Eisai's (TSE:4523) Investment Narrative?
Profile
Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices. Wikipedia
Tungkol sa Eisai Co Ltd
CEOHaruo Naito | Haruo Naito
Mga Empleyado10.5K
ItinatagDis 6, 1941
HeadquartersBunkyÅ, Tokyo, Japan
Sektor-
Websiteeisai.co.jp